Last Updated 2 December 2022.
13 Vaccines Approved for Use in Indonesia
-
Anhui Zhifei Longcom
Zifivax- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 4 countries
21 trials in 5 countries
Approval Source: reuters.com
-
PT Bio Farma
IndoVac- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 1 country
4 trials in 1 country
Approval Source: texaschildrens.org
-
Serum Institute of India
COVOVAX (Novavax formulation)- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 6 countries
7 trials in 3 countries
Approval Source: reuters.com
-
Moderna
Spikevax- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 88 countries
70 trials in 24 countries
Approval Source: reuters.com
-
Pfizer/BioNTech
Comirnaty- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 149 countries
100 trials in 31 countries
Approval Source: reuters.com
-
Walvax
AWcorna- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 1 country
4 trials in 3 countries
Approval Source: reuters.com
-
CanSino
Convidecia- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 10 countries
14 trials in 6 countries
Approval Source: reuters.com
-
Gamaleya
Sputnik V- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 74 countries
25 trials in 8 countries
Approval Source: reuters.com
-
Janssen (Johnson & Johnson)
Jcovden- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 113 countries
26 trials in 25 countries
Approval Source: reuters.com
-
Oxford/AstraZeneca
Vaxzevria- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 149 countries
73 trials in 34 countries
Approval Source: reuters.com
-
Shenzhen Kangtai Biological Products Co
KCONVAC- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 2 countries
7 trials in 1 country
Approval Source: barrons.com
-
Sinopharm (Beijing)
Covilo- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 93 countries
39 trials in 18 countries
Approval Source: reuters.com
-
Sinovac
CoronaVac- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 56 countries
42 trials in 10 countries
Approval Source: reuters.com
17 Vaccines in Clinical Trials in Indonesia
-
Anhui Zhifei Longcom
Zifivax- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 4 countries
21 trials in 5 countries
-
PT Bio Farma
IndoVac- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 1 country
4 trials in 1 country
-
PT Bio Farma
SARS-CoV-2 Protein Subunit Recombinant Vaccine- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 3 trials.
5 trials in 1 country
-
Serum Institute of India
COVOVAX (Novavax formulation)- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 6 countries
7 trials in 3 countries
-
West China Hospital
Recombinant (Sf9 cell)- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 3 trials.
9 trials in 5 countries
-
Moderna
Spikevax- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 88 countries
70 trials in 24 countries
-
Pfizer/BioNTech
Comirnaty- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 149 countries
100 trials in 31 countries
-
Walvax
AWcorna- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 1 country
4 trials in 3 countries
-
Oxford/AstraZeneca
Vaxzevria- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 149 countries
73 trials in 34 countries
-
ReiThera
GRAd-COV2- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 3 trials.
5 trials in 12 countries
-
Airlangga University
UNAIR Inactivated COVID-19 Vaccine- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 3 trials.
3 trials in 1 country
-
Sinopharm (Beijing)
Covilo- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 93 countries
39 trials in 18 countries
-
Sinovac
CoronaVac- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 56 countries
42 trials in 10 countries
-
Adimmune Corporation
AdimrSC-2f- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
3 trials in 2 countries
-
Aivita Biomedical Inc
AV-COVID-19- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
4 trials in 2 countries
-
Suzhou Abogen Biosciences
ABO-CoV.617.2- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 1 trials.
1 trial in 1 country
-
Suzhou Abogen Biosciences
ABO1009-DP- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 1 trials.
2 trials in 2 countries